🇺🇸 FDA
Pipeline program

Generic Estradiol Vaginal Cream USP, 0.01%

71436001

Phase 3 small_molecule completed

Quick answer

Generic Estradiol Vaginal Cream USP, 0.01% for Atrophic Vaginitis is a Phase 3 program (small_molecule) at TEVA PHARMACEUTICAL INDUSTRIES LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TEVA PHARMACEUTICAL INDUSTRIES LTD
Indication
Atrophic Vaginitis
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials